A61K 45 - Medicinal preparations containing active ingredients not provided for in groups

Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
11/2002
11/21/2002	CA2445366A1 Molecules for disease detection and treatment
11/21/2002	CA2443964A1 Use of osteopontin for the treatment and/or prevention of neurologic diseases
11/21/2002	CA2443627A1 Genes expressed in breast cancer as prognostic and therapeutic targets
11/21/2002	CA2443160A1 Cytotoxic peptides and peptidomimetics based thereon, and methods for use thereof
11/20/2002	WO2001091755A1 Active substance combination containing a compound with an opioid effect and at least one further compound of formula i
11/20/2002	EP1258253A1 Novel remedies with the use of beta3 agonist
11/20/2002	EP1258252A1 Integrin expression inhibitors
11/20/2002	EP1258251A1 Compositions for preventing and treating digestive diseases
11/20/2002	EP1258249A1 Oral preparations for diabetes
11/20/2002	EP1258248A2 Tumor treatments comprising a fumagillol derivative and a further antineoplastic agent
11/20/2002	EP1258245A2 Accelerated release composition containing bromocriptine
11/20/2002	EP1258244A1 High affinity ligands for nociceptin receptor ORL-1
11/20/2002	EP1257819A2 Method for identifying substances which modulate the activity of hyperpolarisation-activated cation channels
11/20/2002	EP1257648A1 Antagonistic selective binding agents of osteoprotegerin binding protein
11/20/2002	EP1257646A2 Transporters and ion channels
11/20/2002	EP1257645A2 Fibroblast growth factor-23 molecules and uses thereof
11/20/2002	EP1257635A2 Lipid metabolism enzymes and polynucleotides encoding them
11/20/2002	EP1257585A2 Antibodies that bind human interleukin-18 and methods of making and using
11/20/2002	EP1257578A2 Transporters and ion channels
11/20/2002	EP1257573A2 New transcription factor carp-2
11/20/2002	EP1257563A1 Therapeutic and diagnostic methods for ulcerative colitis and associated disorders
11/20/2002	EP1257560A1 Bcl-2-like polynucleotides, polypeptides, and antibodies
11/20/2002	EP1257526A1 Aniline-derived ligands for the thyroid receptor
11/20/2002	EP1257304A1 Foam-forming wound dressing
11/20/2002	EP1257298A1 Cosmid dna constructs and methods of making and using the same
11/20/2002	EP1257296A2 Caspase activated prodrugs therapy
11/20/2002	EP1257292A1 Use of il-18 inhibitors
11/20/2002	EP1257291A1 Novel antibody with specificity for colon cancer
11/20/2002	EP1257286A2 Cancer treatment and prognosis involving hes-1 protein
11/20/2002	EP1257282A1 Pancreatic stem cells and their use in transplantation
11/20/2002	EP1257277A2 New drug combinations comprising a norepinephrine reuptake inhibitor and an antimuscarinic agent
11/20/2002	EP1257276A1 Antiviral azaindole derivatives
11/20/2002	EP1257275A2 Use of central cannabinoid receptor antagonist for preparing medicines designed to facilitate smoking cessation
11/20/2002	EP1257263A2 Microcompetiton and human disease
11/20/2002	EP1257262A2 Pharmacological agent comprising picolinic acid, fusaric acid and derivatives thereof
11/20/2002	EP1257261A2 Antiviral pharmaceutical compositions containing iron chelators
11/20/2002	EP1257255A1 Therapeutic product, use and formulation thereof
11/20/2002	EP1257248A1 Pharmaceutical composition
11/20/2002	EP1257232A2 Oral therapeutic delivery appliance
11/20/2002	EP1206582A4 Methods and compositions for inhibition of membrane fusion-associated events, including hiv transmission
11/20/2002	EP1140190B1 Combinations of ileal bile acid transport inhibitors and bile acid sequestering agents for cardiovascular indications
11/20/2002	EP1112095B1 Biologically active implants
11/20/2002	EP1098645B1 Compositions comprising phenylaminothiophenacetic acid derivatives for the treatment of acute or adult respiratory distress syndrome (ards) and infant respiratory distress syndrome (irds)
11/20/2002	EP1002542B1 Use of vip for the preparation of a medicament for treating the endotoxic shock in mammals
11/20/2002	EP1001758B1 Method of screening of potential drugs against obesity, capable of modulating the regulation of ucp-2
11/20/2002	EP0984784B1 Anti-cancer products for treating cystic fibrosis
11/20/2002	EP0946189B1 Use of cntf (ciliary neurotrophic factor) receptor activators for the treatment of obesity
11/20/2002	EP0871458B1 Method of decreasing radiation or radio-mimetic chemotherapy for hematopoietic pluripotent cell engraftment
11/20/2002	EP0833828B1 Rapamycin derivatives
11/20/2002	EP0814840B1 Oral pharmaceutical dosage forms comprising a proton pump inhibitor and a prokinetic agent
11/20/2002	EP0813424B1 Oral pharmaceutical dosage forms comprising a proton pump inhibitor and an antacid agent or alginate
11/20/2002	EP0750507B1 Proteasome regulation of nf-kappa-b activity
11/20/2002	CN1380813A Primary composition containing lipophilic bioactive compound
11/20/2002	CN1380106A Thermotherapeutic suppository and its use method
11/20/2002	CN1380064A Method for producing antibiotic preparation and its application
11/20/2002	CN1094350C Preparation for epidermis and process for its preparation
11/19/2002	US6482935 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
11/19/2002	US6482927 Chimeric proteins comprising the extracellular domain of murine Ob receptor
11/19/2002	US6482925 Mutants of the LAG-3 proteins and nucleotides encoding LAG-3 mutants
11/19/2002	US6482857 Compositions which contain triterpenes for regulating hair growth
11/19/2002	US6482856 Method and composition for treating mammalian disease caused by inflammatory response
11/19/2002	US6482846 Compositions and methods to prevent toxicity induced by nonsteroidal antiinflammatory drugs
11/19/2002	US6482811 Bretylium compositions and kits, and their use in preventing and treating cardio-vascular conditions
11/19/2002	US6482802 Use of neomycin for treating angiogenesis-related diseases
11/19/2002	US6482624 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
11/19/2002	US6482623 Lipid kinase
11/19/2002	US6482612 Adipocyte-specific protein homologs
11/19/2002	US6482610 Method for producing agents for treating tumor diseases and for immunosuppression
11/19/2002	US6482609 Isolated human EDG-4 receptor and polynucletide encoding said receptor
11/19/2002	US6482603 Method of detecting drug-receptor and protein-protein interactions
11/19/2002	US6482517 Coated particles, methods of making and using
11/19/2002	US6482426 Compositions for the treatment of male erectile dysfunction
11/19/2002	US6482402 Antimicrobial compositions and methods
11/19/2002	US6481435 Closure-cap and container as a two-chamber cartridge for nebulizers for producing aerosols and active substance formulations, suitable for storage
11/19/2002	CA2252513C Method for the prevention and treatment of cachexia and anorexia
11/19/2002	CA2236422C Hydrolysis-optimized lipid emulsions and use thereof
11/19/2002	CA2219502C Methods and formulations for modulating the human sexual response
11/19/2002	CA2216870C Compositions and methods for regulating hair growth
11/19/2002	CA2154432C Cosmetic and/or dermatologic composition containing thermal or mineral water and an anti-acne and anti-aging active ingredient
11/19/2002	CA2066134C Complexes of polyadenylic acid with polyuridylic acid
11/18/2002	CA2381829A1 A method for tumor treatment with fumagillol derivatives
11/18/2002	CA2381637A1 Compositions and methods for treating or preventing convulsions or seizures
11/16/2002	CA2383556A1 High-efficiency assay for protein mannosyl transferases
11/15/2002	WO2001090053A1 Diphenylmethane derivatives
11/15/2002	CA2409144A1 Diphenylmethane derivatives
11/14/2002	WO2002090980A1 Eyestrain model, method of constructing the same, evaluation method with the use of the model and drugs screened by using the evaluatin method
11/14/2002	WO2002090974A2 Method for detecting progredient chronic dementia, and associated peptides and detection reagents
11/14/2002	WO2002090934A2 Evaluation of ultraviolet radiation damage to skin using new genemarkers, methods and compositions related thereto
11/14/2002	WO2002090600A2 A method for regulating immune function in primates using the foxp3 protein
11/14/2002	WO2002090567A2 Sperm-specific cation channel, and uses therefor
11/14/2002	WO2002090548A1 Method of purifying chromosomal dna replication initiating protein dnaa of pathogenic bacterium using affinity of dnaa protein for atp, method of evaluating antibacterial activity and method of screening compound having antibacterial activity using affinity of dnaa protein for atp
11/14/2002	WO2002090532A1 Novel mutation
11/14/2002	WO2002090530A2 Kinases and phosphatases
11/14/2002	WO2002090520A2 Toll/interleukin-1 receptor adaptor protein (tirap)
11/14/2002	WO2002090515A2 Compositions and methods for reducing cytotoxicity and inhibiting angiogenesis
11/14/2002	WO2002090514A2 Epidermal growth factor receptorantisense oligonucleotides
11/14/2002	WO2002090358A1 Disubstituted 7,9-guaninium halides as telomerase inhibitors
11/14/2002	WO2002090325A2 Benzazepinone alpha v integrin receptor antagonists
11/14/2002	WO2002089853A2 Compositions having enhanced pharmacokinetic characteristics
11/14/2002	WO2002089848A2 Use of an ampa receptor potentiator for the manufacture of a medicament for the treatment of type 2 diabetes

1 ... 766 767 768 769 770 771 772 773 774 775 776 777 778 779 780 781 782 783 784 785 786 ... 1151